Last reviewed · How we verify
NCT03110393
Ambu®AuraGain™ Versus I-gel® in Obese Patients
NA trial testing Ambu AuraGain in Obese in 44 participants. Completed in 6 September 2017.
6 September 2017
Quick facts
| Lead sponsor | Schulthess Klinik |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 20 April 2017 |
| Primary completion | 6 September 2017 |
| Estimated completion | 6 September 2017 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Ambu AuraGain
- Intersurgical i-gel
Conditions studied
- Obese — all drugs for Obese →
Sponsor
Schulthess Klinik
Who can join
Adults 18 to 70, any sex, with Obese. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is the randomized comparison of two laryngeal mask (Intersurgical i-gel® and Ambu®AuraGain™) in obese patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03110393
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ambu AuraGain
Trials testing the same drug.
- NCT02724956 — Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients · NA · completed
- NCT03108391 — A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients · NA · unknown
Other recruiting trials for Obese
Currently open trials in the same condition.
- NCT07411560 — A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in Peopl · Phase 1 · recruiting
- NCT06719466 — Diet Intervention on Obesity Related Complication · NA · active not recruiting
- NCT06590584 — Validity and Reliability of the 6-minute Pegboard Ring Test in Obese Individuals · recruiting
- NCT06562660 — The Effect of Mask Combined With High Flow Oxygen on Preoxygenation During Induction of General Anesthesia in Obese Pati · NA · recruiting
- NCT05819853 — Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome · Phase 3 · recruiting
Other Schulthess Klinik trials
Trials by the same sponsor.
- NCT07197593 — Validity and Reliability of Calf Raise Tests in Patients With Achilles Tendon Rupture and Lateral Ankle Sprain · NA · not yet recruiting
- NCT06223737 — Spine Deformity Patients With Optoelectronic Motion Capture · NA · not yet recruiting
- NCT06330129 — Validity and Reliability of Trunk Strength Device · NA · completed
- NCT06612853 — Validation of the Single-item Sleep Quality Scale · recruiting
- NCT06555991 — Translation and Validation of the SIRSI and TSK-SI Into German · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03110393 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Schulthess Klinik
- Last refreshed: 8 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03110393.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing